The circulating common gamma chain (CD132) in inflammatory bowel disease

American Journal of Gastroenterology

Volumn 93, Issue 3, 1998, Pages 323-328

  Nielsen, Ole Haagen ^a   Kirman, Irena ^b   Johnson, Kirk ^b   Giedlin, Martin ^b   Ciardelli, Thomas ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; MESALAZINE; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2;

EID: 0032033981     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00323.x     Document Type: Article

References (39)

1. 1. Mahida YR, Gallagher A, Kurlak L, et al. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 1990;82:75-80.
2. 2. Matsuura T, West GA, Klein JS, et al. Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 1992;102:2006-14.
3. 3. Schürmann G, Betzler M, Post S, et al. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1β in patients with Crohn's disease and ulcerative colitis: Preoperative levels and postoperative changes of serum concentrations. Digestion 1992;51:51-9.
4. 4. Krause A, Henrich A, Beckh KH, et al. Correlation between density of β2-adrenergic receptors on peripheral blood mononuclear cells and serum levels of soluble interleukin-2 receptors in patients with chronic inflammatory diseases. Eur J Clin Invest 1992;22(suppl 1):47-51.
5. 5. Matsuura T, West GA, Youngman KR, et al. Immune activation genes in inflammatory bowel disease. Gastroenterology 1993;104:448-58.
6. 6. Ebert EC, Wright SH, Lipshutz WH, et al. T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2 Clin Immunol Immunopathol 1984;33:232-44.
7. 7. Hémar A, Lieb M, Subtil A, et al. Endocytosis of the β chain of interleukin-2 receptor requires neither interleukin-2 nor the y chain. Eur J Immunol 1994;24:1951-5.
8. 8. Sadlack B, Lohler J, Schorle H, et al. Gerenalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995;25: 3053-9.
9. 9. Bachmann WF, Schorle H, Kuhn R, et al. Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J Virol 1995;69:4842-6.
10. 10. Simpson SJ, Mizoguchi E, Allen D, et al. Evidence that CD4+, but not CDS+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-25.
11. 11. Takeshita T, Asao H, Ohtani K, et al. Cloning of the γ chain of the human IL-2 receptor. Science 1992;257:379-82.
12. 12. Thèze J, Alzari PM, Bertoglio J. Interleukin 2 ind its receptors: Recent advances and new immunological functions. Immunol Today 1996; 17:481-6.
13. 13. Matthews DJ, Clark PA, Herbert J, et al. Function of the interleukin-2 receptor in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL 15. Blood 1995;85:38-42.
14. 14. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996;31(suppl 216):149-59.
15. 15. Nielsen OH, Brynskov J. Soluble interleukin-2 receptors (sIL-2R) in ulcerative colitis: Correlation with disease activity. Mediat Inflamm 1993;2:115-8.
16. 16. Sugamura K, Takeshita T, Asao H, et al. The IL-2/IL-2 receptor system: Involvement of a novel receptor subunit, gamma chain, in growth signal transduction. Tohoku J Exp Med 1992;168:231-7.
17. 17. Takeshita T, Ohtani K, Asao H, et al. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J Immunol 1992:148:2154-8.
18. 18. Kirman I, Nielsen OH, Expression of the common gamma chain on peripheral blood mononuclear cells in Crohr's disease. Dig Dis Sci 1997;42:372-7.
19. 19. Langholz E, Munkholm P, Nielsen OH, et al. Incidence and prevalence of ulcerative colitis in the county of Copenhagen 1962 to 1987. Scand J Gastroenterol 1991;26:1247-56.
20. 20. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-1987: A six fold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
21. 21. Tvede M, Bondesen S, Nielsen OH, et al. Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol 1983;18:783-9.
22. 22. Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 1996;91:1789-94.
23. 23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
24. 24. Johnson K, Choi Y, Wu Z, et al. Soluble IL-2 receptor β and γ subunits: Ligand binding and cooperativity. Eur Cytokine Netw 1994; 5:23-34.
25. 25. Schreiber S, Raedler A, Conn AR, et al. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. Gut 1992;33:236-41.
26. 26. Balasubramanian S, Chernov-Rogan T, Davis AM, et al. Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. Int Immunol 1995;7: 1839-49.
27. 27. Sharon M, Klausner RD, Cullen BR, et al. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 1986;234:859-63.
28. 28. Symons JA, Wood NC, diGiovine FS, et al. Soluble interleukin 2 receptors in rheumatoid arthritis: Correlations with disease activity, interleukin 1 and interleukin 2 inhibitors. J Immunol 1988;141:2612-8.
29. 29. Reinecker HC, Podolsky DK. Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor. Proc Natl Acad Sci USA 1995;92:8353-7.
30. 30. Tvede N, Brynskov J. Interleukin-2 stimulation of blood mononuclear cells from patients with inflammatory bowel disease. APMIS 1991; 99:759-64.
31. + phenotype and defective proliferation response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110:1008-19.
32. 32. Crabtree JE, Juby LD, Heatley RV, et al. Soluble interleukin-2 receptor in Crohn's disease: Relation of serum concentrations to disease activity. Gut 1990;31:1033-6.
33. 33. Mueller C, Knoflach P, Zielinski CC. T-cell activation in Crohn's disease: Increased levels of soluble interleukin-2 receptor in serum and supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990;98:639-46.
34. 34. Williams AJK, Symons JA, Watchet K, et al. Soluble interleukin-2 receptor and disease activity in Crohn's disease. J Autoimmun 1992; 5:251-9.
35. 35. Nielsen OH, Ciardelli T, Wu Z, et al. Circulating soluble interleukin-2 receptor α and β chain in inflammatory bowel disease. Am J Gastroenterol 1995;90:1301-6.
36. 36. Hart PH, Vitti GF, Burgess DR, et al. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803-7.
37. 37. Cheung DL, Hart PH, Vitti GF, et al. Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 1990;71:70-5.
38. 38. Schreiber S, Heinig T, Panzer U, et al. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995;108:21-33.
39. 39. Stevens C, Lipman M, Fabry S, et al. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peropheral blood mononuclear cells. J Pharmacol Exp Ther 1995;272:399-406.